Status
Conditions
Treatments
About
honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated
Full description
Forty fatty liver (non-alcoholic from) patients with obesity are included to be divided into group 1 who will contain 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. Group 2 who will contain 20 patients who will receive low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
Alshaymaa S Abd El-Azeim, Lecturer; Ali MA Isamil, Lecturer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal